|Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials (CDM-J).
|Pharmacoepidemiology & Drug Safety
|Clinical and pharmacoeconomic combined report: romosozumab.
|Importance of time point–specific indirect treatment comparisons of osteoporosis treatments: a systematic literature review and network meta-analyses.
|Efficacy and safety of anti-sclerostin antibodies in the treatment of osteoporosis: A meta-analysis and systematic review.
|Journal of Clinical Densitometry
|Romosozumab versus teriparatide for the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis through a grade analysis of evidence.
|Antiresorptive and anabolic medications used in the perioperative period of patients with osteoporosis undergoing spine surgery: their impact on the biology of fusion and systematic review of the literature.
|Journal of Neurosurgery
|A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
|Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
|Denosumab and romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: a reanalysis of the meta-analysis.
|Risk of falls in postmenopausal women treated with romosozumab: preliminary indices from a meta-analysis of randomized, controlled trials.
|Osteoporosis and Sarcopenia
|Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data.
|Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta-analysis.
|Safety of romosozumab in osteoporotic men and postmenopausal women: a meta-analysis and systematic review.
|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|Assessment report: evenity.
|Comparative efficacy and safety of pharmacological interventions for osteoporosis in postmenopausal women: a network meta-analysis (Chongqing, China).
|Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis.
|The Journal of Clinical Endocrinology and Metabolism
|Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: a systematic review and network meta-analysis of randomized controlled trials.
|Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials.
|BMC Musculoskeletal Disorders